Predict your next investment

Aperta Biosciences company logo
HEALTHCARE | Biotechnology
apertabio.com

See what CB Insights has to offer

Founded Year

2017

Stage

Debt | Alive

Total Raised

$180K

Last Raised

$180K | 3 yrs ago

About Aperta Biosciences

Aperta Biosciences develops safe and effective therapeutics for chronic inflammatory ophthalmic diseases.

Aperta Biosciences Headquarter Location

20 S. Sarah Street

Saint Louis, Missouri, 63108,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Aperta Biosciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Aperta Biosciences is included in 2 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Aperta Biosciences Patents

Aperta Biosciences has filed 2 patents.

The 3 most popular patent topics include:

  • Diseases of the eye and adnexa
  • Disorders of sclera and cornea
  • Dog diseases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/26/2019

8/4/2020

Trifluoromethyl compounds, Diseases of the eye and adnexa, Disorders of sclera and cornea, Inflammations, Phenols

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

7/26/2019

00/00/0000

Grant Date

8/4/2020

00/00/0000

Title

Subscribe to see more

Related Topics

Trifluoromethyl compounds, Diseases of the eye and adnexa, Disorders of sclera and cornea, Inflammations, Phenols

Subscribe to see more

Status

Grant

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.